eISSN: 2299-0046
ISSN: 1642-395X
Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii
Current issue Archive Manuscripts accepted About the journal Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
1/2014
vol. 31
 
Share:
Share:
abstract:

Case report
Omalizumab treatment in brittle asthma

Roman Skiepko
,
Ziemowit Zietkowski
,
Urszula Skiepko
,
Wojciech Budny
,
Mateusz Lukaszyk
,
Anna Bodzenta-Lukaszyk

Postep Derm Alergol 2014; XXXI, 1: 36–38
Online publish date: 2014/02/25
View full text Get citation
 
Asthma is a heterogeneous disease with variable characteristics such as lung function, symptoms and control, body weight, pattern of inflammation, and response to treatment. Brittle asthma is one of clinical phenotypes of asthma with unclear pathogenic mechanisms and appropriate treatment. Analysis of 2 described cases suggests that omalizumab could be useful in the treatment of brittle allergic asthma.
keywords:

brittle asthma, omalizumab

Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.